Brief: Novartis Plans To Establish 46,000-Square-Foot Radioligand Therapy Manufacturing Site In Texas
25/02/2026 12:00
Feb 25 (Reuters) - Novartis NOVN.S: NOVARTIS: PLANS TO ESTABLISH NEW 46,000-SQUARE-FOOT RADIOLIGAND THERAPY MANUFACTURING SITE IN DENTON, TEXAS NOVARTIS: CONSTRUCTION SCHEDULED TO BEGIN THIS YEAR, WITH SITE EXPECTED TO BECOME FULLY OPERATIONAL IN 2028 Further company coverage: NOVN.S ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Novartis AG
See all newsBrief: Novartis Remind Data At Eaaci Show Rhapsido Potential As First Targeted Therapy For Chronic Inducible Urticaria (Cindu)
Swiss stocks - Factors to watch on June 12
Swiss pharma hub Basel frets over population cap threat
Novartis says rare muscle disease drug shows promise in early trial
Live Markets: Europe at half-time: countdown to the ECB's 'insurance hike'